Client News
Medigene AG: Medigene appoints Axel-Sven Malkomes as CFO/CBDO
Adrenomed AG announces publication of Phase II trial design of Adrecizumab to treat septic shock
InflaRx Announces Presentation of New Clinical Data with Lead Candidate IFX-1 in Hidradenitis Suppurativa
MagForce AG: Newly launched ’NanoTherm® Therapy School’ kicks off with successful first training session
MorphoSys Announces Appointment of David Trexler as President and Member of the Board of Directors of MorphoSys US Inc.
Motif Bio plc: Exercise of Warrants
NOXXON Pharma: new data published supporting monotherapy activity of CCL2 inhibitor NOX-E36 in an additional solid tumor type: liver cancer
Ergomed 2018 Trading Update
Biom’up appoints George Makhoul as Chief Commercial Officer (USA)
